As of January 1st, 2018 the responsibility for this Resource Centre has been assumed by the European Association of Eurology
New content this month
Symptom prevalence, bother, and treatment satisfaction in men with lower urinary tract symptoms in Southeast Asia: a multinational, cross-sectional survey
Ho, LY., Chu, P.SK., Consigliere, D.T. et al.World Journal of Urology Urol (2017). https://doi.org/10.1007/s00345-017-2097-2
Sleep disturbance in men receiving androgen deprivation therapy for prostate cancer: The role of hot flashes and nocturia
Gonzalez BD, Small BJ, Cases MG et al.Cancer. 2017 Oct 26. doi: 10.1002/cncr.31024
By Philip van Kerrebroeck
Are lower dosages of desmopressin of real benefit in clinical practice?
In several European countries, low dose formulations of desmopressin (Nocdurna 25 μg for females and Nocdurna 50 μg for males) are registered for the specific indication of nocturia due to nocturnal polyuria. This registration is based on the earlier registration of the higher dose melt formulations of desmopressin (Minrin melt 60 μg, 120 μg and 240 μg) for the same indication and two pivotal US trials with lower, gender-specific dosages...
World Sleep Day on March 17, 2017
An important question in nocturia is: do patients awake by the need to void, or do they void after being awaken for some other reasons? Will there be a true answer? On World Sleep Day 2017 Professor Bliwise dicusses this topic on the basis of two papers bearing relevance to each hypothesis.
About the Associate Editors
- Dr Antonella Giannantoni is Associate Professor of Urology at the Department of Urology and Andrology, University of Perugia, Italy. She...
- Philip E.V. Van Kerrebroeck is Professor of Urology at the University of Maastricht, and works as a urologist at the...